Multi-National & Multi-Site PTSD-based Clinical Trial Leads to FDA Expansion of Access to Ecstasy
Jan 28, 2020 | CNS, Ecstasy, MDMA, Post Traumatic Stress Disorder, PTSD, Stress, The Multidisciplinary Association for Psychedelic Studies
Because of successful clinical trials including those in Mount Pleasant, South Carolina conducted by therapist Michael Mithoefer, the Food and Drug Administration (FDA) have expanded the use of ecstasy guided therapy—known as MDMA—which is an illegal drug often...
Stanford Researchers Pre-Clinical Research Reveals Party Drug's Therapeutic and Addictive Qualities
Dec 13, 2019 | Central Nervous System, CNS, Ecstasy, MDMA, Methylenedioxy-methamphetamine
Stanford University School of Medicine investigators have successfully distinguished the molecular pathway responsible for Methylenedioxy-methamphetamine (MDMA aka ecstasy) abuse potential from the one behind its propensity to make people feel sociable. MDMA is a mind...
The Landing: Awaiting FDA Approval to be the First MDMA Treatment Clinic in America for Treatment & Clinical Trials
Aug 28, 2019 | CNS, MDMA, Mental Health, PTSD, Treatment-Resistant PTSD
MDMA is now recognized as a serious prospective cure for emotional trauma and a new clinic in Pennsylvania may become the first legally-sanctioned dedicated facility for using the psychoactive drug on treatment-resistant PTSD in the United States. Called the Landing,...
Imperial College of London Clinical Trial for MDMA-Assisted Alcoholism Therapy Shows Promise
Jul 19, 2019 | Alcoholism, CNS, Imperial College of London, MDMA, Substance Use Disorder
Last year the Imperial College of London conducted a clinical trial for the treatment of alcoholism through use of MDMA-assisted therapy. This results are a smashing success. We follow up with the TrialSite News Q&A breakdown of the Imperial College of London...